Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-07

FDA Approved: LEVORPHANOL TARTRATE — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approves a supplemental application for Levorphanol tartrate submitted by SpecGx LLC. The approval pertains to changes under the supplemental filing for thi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levorphanol Tartrate (Levorphanol Tartrate)

Snippet

SUPPL AP for LEVORPHANOL TARTRATE (LEVORPHANOL TARTRATE)